DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $942 | +11.6% | 63,800 | -2.4% | 0.00% | 0.0% |
Q2 2023 | $844 | -60.5% | 65,400 | -70.0% | 0.00% | +33.3% |
Q1 2023 | $2,139 | +193.8% | 218,100 | +218.4% | 0.00% | 0.0% |
Q4 2022 | $728 | -99.9% | 68,500 | -8.3% | 0.00% | -25.0% |
Q3 2022 | $779,000 | -15.5% | 74,700 | +1.9% | 0.00% | 0.0% |
Q2 2022 | $922,000 | +236.5% | 73,300 | +189.7% | 0.00% | +300.0% |
Q1 2022 | $274,000 | -22.8% | 25,300 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $355,000 | -27.0% | 25,300 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $486,000 | – | 25,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |